Cepheid (CPHD) Reports Q4 EPS of 7c, Offers FY16 Guidance
Tweet
Share
E-mailGet Alerts CPHD Hot Sheet
Price: $52.95 --0%
Financial Fact:
Basic net income (loss) per share: -0.15
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Basic net income (loss) per share: -0.15
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Cepheid (NASDAQ: CPHD) reported Q4 EPS of $0.07, may not compare to the analyst estimate of ($0.20). Revenue for the quarter came in at $147 million versus the consensus estimate of $146.91 million.
GUIDANCE:
Cepheid sees FY2016 EPS of $0.22-$0.28, may not compare to the consensus of ($0.48). Cepheid sees FY2016 revenue of $618-635 million, versus the consensus of $622.43 million.
For earnings history and earnings-related data on Cepheid (CPHD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
